Kenvue Aktie News

A Texas state judge won't block Kenvue from paying its scheduled November 26 shareholder dividend, rejecting a request by Texas Attorney General Ken Paxton, a Kenvue lawyer told Reuters on Friday.

A Texas judge on Friday will consider state Attorney General Ken Paxton's bid to block Kenvue from paying a $398 million dividend to shareholders and from marketing Tylenol as safe for pregnant women.

The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from the use of Tylenol by pregnant women.

No single month beats November for S&P 500 stock market performance. And a handful of stocks are already taking off.

Enbridge has a low-risk business that pays a steady and growing dividend. Kenvue's pending acquisition by Kimberly-Clark creates a great opportunity for income investors.

Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) suffer from sector-specific headwinds, with ARE hurt by biotech weakness and RHI by declining revenue and a negative outlook. Molina Healthcare (MOH) and Baxter (BAX) face earnings cuts and operation...